November 16, 2006. The Enhancing Drug Safety and Innovation Act is an important effort to respond to consumers’ increasing concerns about the inadequacy of current safeguards protecting the public from unreported risks of prescription drugs.
Read More »On Health Policy
Letter to USDA Regarding Changes to Improve Nutrition of WIC Foods
November 3, 2006. The National Research Center for Women & Families strongly supports the WIC Food Packages Proposed Rule. A healthful diet is a family responsibility, but WIC policies are essential in encouraging the best possible nutrition for low-income families, and a healthy start for young children.
Read More »NCHR Report on FDA Advisory Committees: Does Approval Mean Safety?
NCHR’s research report on FDA Advisory Committee meetings found problems with bandwagon voting and major disparities between voting members’ criticisms of evidence and their voting behavior. Some types of Advisory Committee members are more skeptical about the evidence and others tend to support industry claims.
Read More »Letter to the Senate HELP Committee on Enhancing Drug Safety and Innovation Act
September 28, 2006. NCHR was disappointed to hear that the Senate is considering marking up S. 3807 “The Enhancing Drug Safety and Innovation Act” before holding a hearing.
Read More »Invited Testimony Before the Standing Committee on Health, Canadian Parliament, Ottawa
June 8, 2006. Clinical trials are a major source of information on the short-term risks of silicone breast implants. In clinical trials, the goal is to follow women prospectively to determine what complications and health problems occur, and to compare that to a control group.
Read More »